Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet lysate versus platelet-rich plasma for chronic knee osteoarthritis
IRCT20160422027520N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2019
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet lysate and platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Knee pain by visual analog scale, Knee function by WOMAC and 2 more. Started Feb 2019; status: completed.
02
Drugs
platelet lysateplatelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20160422027520N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160422027520N10.